HellasMed, LLC – Trademark Portfolio
Entity Type: 16
HellasMed, LLC owns a portfolio of 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as BIOMEAI, AWESOME WOMAN, and AWESOME HEALTH. Of these, 3 are registered. The portfolio spans 4 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 44 (Medical Services). Headquartered in Houston, TX.
3614 University Blvd
Houston, TX 77005
Showing of trademarks Trademarks
Trademark Classifications
HellasMed, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does HellasMed, LLC have?
HellasMed, LLC has 17 U.S. trademarks filed with the USPTO. Of these, 3 registered, 13 abandoned, 1 cancelled.
What trademark classes does HellasMed, LLC file in?
HellasMed, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are HellasMed, LLC's most well-known trademarks?
HellasMed, LLC's registered trademark portfolio includes well-known marks such as BIOMEAI, AWESOME WOMAN, and AWESOME HEALTH. These are among 3 currently registered trademarks in the portfolio.
What is HellasMed, LLC's trademark registration success rate?
HellasMed, LLC has a 18% trademark registration rate, with 3 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.